Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of AK-R215 vs Components in Healthy Volunteers
NCT03321318Phase 1Unknown
- Sponsor
- Alvogen
- Start
- Jul 2017
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bazedoxifene and vitamin d in postmenopausal osteoporosis (2 arms), sponsored by Alvogen. Primary endpoints: Area Under the Curve from time 0 to last measurable concentration at 120 hours and Maximum Plasma Concentration at 120 hours. Status: unknown.
02
Drugs
bazedoxifenevitamin d
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT03321318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321318.